Skip to main content

Axe Compute Inc.

corporate_fare Company Profile

Axe Compute Inc.

Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed AGPU - Latest Insights

AGPU
Apr 22, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
10
AGPU
Apr 16, 2026, 5:02 PM EDT
Source: Reuters
Importance Score:
8
AGPU
Apr 16, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
AGPU
Apr 16, 2026, 1:07 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
AGPU
Apr 01, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
9
AGPU
Mar 31, 2026, 4:34 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
AGPU
Mar 31, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
AGPU
Mar 31, 2026, 4:15 PM EDT
Filing Type: 10-K
Importance Score:
10
AGPU
Mar 09, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
7
AGPU
Feb 09, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
9
AGPU
Jan 22, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7